{
  "timestamp": "20250104_005004",
  "model": "gpt-4o-mini",
  "interaction_type": "answer_with_enhancement_kg_only",
  "question_id": "c26f7748",
  "question_text": "Myoclonus in children is best treated by :",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on enhanced information."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.\n                    You are a medical expert determining the final answer.\n\n            ### Instructions:\n            - Use standard medical knowledge as the primary guide.\n            - Consider enhanced information only if it aligns with consensus.\n            - If conflicting or unclear, present the most likely correct answer based on known facts.\n            - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n\n\n                    ### Question\n                    Myoclonus in children is best treated by :\n\n                    ### Options\n                    opa. Clonazepam\nopb. Sodium Valproate\nopc. Phenobarbitone\nopd. Ethosuximide\n\n### Enhanced Information (For Contextual Support):\nMyoclonus in children is often associated with epilepsy and can be effectively treated with certain anticonvulsants. Clonazepam is recognized as effective for myoclonic seizures, as it reduces myoclonic jerks and is commonly used in clinical practice. Sodium Valproate is also used for various seizure types, including some myoclonic cases, but is not as effective as Clonazepam for this specific condition. Phenobarbitone is a barbiturate anticonvulsant that is less effective for myoclonic seizures and is not considered a first-line treatment. Ethosuximide primarily treats absence seizures and is not recommended for myoclonic seizures. Therefore, the best treatment option for myoclonus in children is Clonazepam, supported by its established efficacy in managing myoclonic seizures.\n\n                    ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n\n                ### Output Format:\n                {\n                  \"final_analysis\": \"Step-by-step reasoning, prioritizing medical consensus and acknowledging complexity if present.\",\n                  \"answer\": \"Option key (e.g. opa, opb, ...)\",\n                  \"confidence\": A number between 0-100\n                }\n                    "
    }
  ],
  "response": "{\n  \"final_analysis\": \"Myoclonus in children, particularly when associated with epilepsy, is best treated with medications that specifically target myoclonic seizures. Clonazepam is well-documented in clinical practice as effective for reducing myoclonic jerks and is often used as a first-line treatment. Sodium Valproate is also effective for various seizure types, including myoclonic seizures, but it is not as targeted as Clonazepam for this specific condition. Phenobarbitone is less effective for myoclonic seizures and is not a preferred choice. Ethosuximide is primarily used for absence seizures and does not address myoclonic seizures. Therefore, based on the consensus in pharmacological treatment for myoclonus, Clonazepam is the best option. The reasoning aligns with established medical knowledge and clinical practice guidelines.\",\n  \"answer\": \"opa\",\n  \"confidence\": 90\n}",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4o-mini",
    "temperature": 0.0
  }
}